Spruce Biosciences Inc

Spruce Biosciences Inc is an American clinical-stage biopharmaceutical company dedicated to developing innovative therapies. Its primary activity involves advancing drug candidates designed to address rare endocrine disorders, aiming to fulfil significant unmet medical needs for affected patient populations. Operating within the biotechnology and pharmaceutical sector, Spruce Biosciences Inc specifically focuses on its lead investigational therapy, tildacerfont. This oral antagonist aims to normalise hormone levels and improve clinical outcomes for individuals suffering from specific chronic endocrine conditions. Keep up to date on the latest share price changes by adding SPRB stock to your eToro watchlist. This content was generated by artificial intelligence. We cannot guarantee the accuracy, completeness, or timeliness of the information provided.